|
|
|
|
n-chromosome royal jelly, propolis and bee pollen supplementation improve the clinical conditions of covid-19 patients: a randomized controlled trial
|
|
|
|
|
|
|
|
نویسنده
|
abedini atefeh ,shafaghi shadi ,ameri ahmad zahra ,javanmardi elmira ,ghorbani fariba ,sharif-kashani babak ,naghashzadeh farah ,shafaghi masoud ,moshirpour melina ,noorali sima ,hakimian hoda ,keshmiri mohammad sadegh ,fazlzadeh aylar
|
|
منبع
|
traditional and integrative medicine - 2021 - دوره : 6 - شماره : 4 - صفحه:360 -369
|
|
چکیده
|
Royal jelly, propolis, and bee pollen are used for different purposes all around the world according to their anti-inflammatory, antioxidant, and antimicrobial activities. given that coronavirus 2019 (covid-19) is a viral condition accompanied by a dysregulated inflammatory response in the body, we intend to evaluate the effects of natural supplementations on the disease course. a randomized, open-label, controlled trial was conducted among 50 definitive cases of covid-19. these patients were randomly assigned into control and intervention groups. royal jelly, propolis, and bee pollen were prescribed to patients in the intervention group (n = 24) in addition to conventional treatment; while the control group only received the standard treatment (n = 26). at the end of the study, functional class improved in both groups, but this change was more pronounced in the intervention group (p < 0.05). moreover, total symptoms duration and the time to return to work were significantly reduced in the intervention group (p < 0.05). although royal jelly, propolis, and bee pollen are not definitive treatments in covid-19 patients, they can be used as an adjuvant treatment to limit disease symptoms and virus propagation.
|
|
کلیدواژه
|
royal jelly ,bee pollen ,propolis ,hyperinflammation ,corona virus disease 2019 (covid-19)
|
|
آدرس
|
shahid beheshti university of medical sciences, chronic respiratory diseases research center, national research institute of tuberculosis and lung diseases (nritld), iran, shahid beheshti university of medical sciences, lung transplantation research center, national research institute of tuberculosis and lung diseases (nritld), iran, shahid beheshti university of medical sciences, chronic respiratory diseases research center, national research institute of tuberculosis and lung diseases (nritld), iran, zanjan university medical school, heart center, ayatoullah mousavi hospital, department of cardiovascular medicine, iran, shahid beheshti university of medical sciences, tracheal diseases research center, national research institute of tuberculosis and lung diseases, iran, shahid beheshti university of medical sciences, tobacco prevention and control research center, national research institute of tuberculosis and lung diseases (nritld), iran, shahid beheshti university of medical sciences, lung transplantation research center, national research institute of tuberculosis and lung diseases (nritld), iran, , strategic planning and executive office manager of international federation of inventors’ associations ifia, switzerland, shahid beheshti university of medical sciences, lung transplantation research center, national research institute of tuberculosis and lung diseases (nritld), iran, shahid beheshti university of medical sciences, lung transplantation research center, national research institute of tuberculosis and lung diseases (nritld), iran, shahid beheshti university of medical sciences, lung transplantation research center, national research institute of tuberculosis and lung diseases (nritld), iran, shahid beheshti university of medical sciences, lung transplantation research center, national research institute of tuberculosis and lung diseases (nritld), iran, shahid beheshti university of medical sciences, lung transplantation research center, national research institute of tuberculosis and lung diseases (nritld), iran
|
|
پست الکترونیکی
|
dr.aylar.fazlzadeh@gmail.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|